Seroprevalence Studies May Underestimate Immunity To The Coronavirus

Dr. Rajkumar is convinced that seroprevalence studies greatly underestimate the true level of immunity of a given population to the novel coronavirus. Antibody production upon exposure to the virus, existing antibodies, and T cells all contribute to immunity.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Tags: Healthcare /healthcare Innovation /innovation Coronavirus business pharma & Source Type: news